☰

Haijun Ma, Ph.D.

Affiliations: 
2006 University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Biostatistics Biology, Public Health
Google:
"Haijun Ma"
Cross-listing: MathTree

Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Bradley P. Carlin grad student 2006 UMN
 (Bayesian hierarchical boundary analysis for areal public health data.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ma H, Russek-Cohen E, Izem R, et al. (2018) Sources of Safety Data and Statistical Strategies for Design and Analysis: Transforming Data Into Evidence. Therapeutic Innovation & Regulatory Science. 52: 187-198
Izem R, Sanchez-Kam M, Ma H, et al. (2018) Sources of Safety Data and Statistical Strategies for Design and Analysis: Postmarket Surveillance. Therapeutic Innovation & Regulatory Science. 52: 159-169
Zink RC, Marchenko O, Sanchez-Kam M, et al. (2018) Sources of Safety Data and Statistical Strategies for Design and Analysis: Clinical Trials. Therapeutic Innovation & Regulatory Science. 52: 141-158
Marchenko O, Jiang Q, Chuang-Stein C, et al. (2017) Statistical Considerations for Cardiovascular Outcome Trials in Patients with Type 2 Diabetes Mellitus Statistics in Biopharmaceutical Research. 9: 347-360
Zhao H, Hobbs BP, Ma H, et al. (2016) Combining Non-randomized and Randomized Data in Clinical Trials Using Commensurate Priors. Health Services & Outcomes Research Methodology. 16: 154-171
Zhao H, Hodges JS, Ma H, et al. (2016) Hierarchical Bayesian approaches for detecting inconsistency in network meta-analysis. Statistics in Medicine
Ma H, Jiang Q, Chuang-Stein C, et al. (2016) Considerations on Endpoint Selection, Weighting Determination, and Uncertainty Evaluation in the Benefit-Risk Assessment of Medical Product Statistics in Biopharmaceutical Research. 8: 417-425
Ma H, Ke C, Jiang Q, et al. (2015) Statistical Considerations on the Evaluation of Imbalances of Adverse Events in Randomized Clinical Trials. Therapeutic Innovation & Regulatory Science. 49: 957-965
Marchenko O, Jiang Q, Chakravarty A, et al. (2015) Evaluation and Review of Strategies to Assess Cardiovascular Risk in Clinical Trials in Patients with Type 2 Diabetes Mellitus Statistics in Biopharmaceutical Research. 7: 253-266
Ohlssen D, Price KL, Xia HA, et al. (2014) Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis. Pharmaceutical Statistics. 13: 55-70
See more...